Search

Admedus taps investors for $28m

Biotech company Admedus has initiated a capital raising comprising a placement and rights issue, with the hope of generating up to $28 million to fund ongoing development of various health care programs.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Client advisers

3rd-Euroz Securities37
4th-Bell Potter Securities28
5th↑Morgans Financial25
6th↑CPS Capital Group25
7th-Shaw and Partners22
20 stockbrokers ranked by number of client advisers in WA

BNiQ Disclaimer